-
1
المؤلفون: Lauren Moran, Wei-Sheng Huang, Yaoyu Ning, Dong Zou, Scott Wardwell, Emily Y. Ye, Frank Wang, Rachel M. Squillace, Lindsey W. Eichinger, Victor M. Rivera, Jeff Keats, Sen Zhang, William C. Shakespeare, Yihan Wang, Sara Nadworny, Shuangying Liu, Tianjun Zhou, Youngchul Song, Xiaotian Zhu, Tim Clackson, David Miller, Hyun Gyung Jang, Narayana I. Narasimhan, Rana Anjum, David C. Dalgarno, Qurish K. Mohemmad, Juan J. Miret
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research. 22(22)
مصطلحات موضوعية: 0301 basic medicine, Alectinib, Cancer Research, Lung Neoplasms, Brigatinib, medicine.drug_class, Pyridines, Antineoplastic Agents, Biology, 03 medical and health sciences, 0302 clinical medicine, Organophosphorus Compounds, Crizotinib, hemic and lymphatic diseases, Carcinoma, Non-Small-Cell Lung, Cell Line, Tumor, medicine, ROS1, Anaplastic lymphoma kinase, Humans, Anaplastic Lymphoma Kinase, Sulfones, Protein Kinase Inhibitors, Ceritinib, ALK Gene Rearrangement, Receptor Protein-Tyrosine Kinases, Hep G2 Cells, U937 Cells, ALK inhibitor, 030104 developmental biology, Pyrimidines, Oncology, Biochemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, Cancer research, Pyrazoles, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a954184cf0503cf7aa96ae269a34c3cb
https://pubmed.ncbi.nlm.nih.gov/27780853 -
2
المؤلفون: Biplab Das, Yun Zhang, Theresa E. Baker, Xiaotian Zhu, Emily Y. Ye, Meera Tugnait, Wei-Sheng Huang, Tianjun Zhou, Yongjin Xu, Narayana I. Narasimhan, Yaoyu Ning, Hyun Gyung Jang, William C. Shakespeare, David C. Dalgarno, Paul M. Taslimi, Scott Wardwell, Sen Zhang, Sara Nadworny, Victor M. Rivera, Francois Gonzalvez, Willmen Youngsaye, Anna Kohlmann, Feng Li, Gong Yongjin, Matthew T. Greenfield, Stephan G. Zech
المصدر: Cancer Research. 76:2644-2644
مصطلحات موضوعية: 0301 basic medicine, Cancer Research, Mutation, Afatinib, Biology, Resistance mutation, medicine.disease_cause, Molecular biology, 03 medical and health sciences, Exon, T790M, 030104 developmental biology, 0302 clinical medicine, Gefitinib, Oncology, 030220 oncology & carcinogenesis, medicine, Erlotinib, Tyrosine kinase, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cd3fc4ce5785604d73f92e73f1327360
https://doi.org/10.1158/1538-7445.am2016-2644 -
3
المؤلفون: Wei-Sheng Huang, Anna Kohlmann, Emily Y. Ye, Yaoyu Ning, Sen Zhang, Lisi Cai, Narayana I. Narasimhan, Feng Li, Tim Clackson, Xiaotian Zhu, David C. Dalgarno, Yongjin Xu, Victor M. Rivera, William C. Shakespeare, Scott Wardwell, Tianjun Zhou
المصدر: Cancer Research. 75:2827-2827
مصطلحات موضوعية: Cancer Research, biology, Oncogene, Crizotinib, medicine.drug_class, Chemistry, Pharmacology, medicine.disease, Receptor tyrosine kinase, ALK inhibitor, Fusion gene, Oncology, Protein kinase domain, hemic and lymphatic diseases, biology.protein, medicine, Anaplastic lymphoma kinase, Anaplastic large-cell lymphoma, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::373c083a07987e1adb50ddc2554ef367
https://doi.org/10.1158/1538-7445.am2015-2827 -
4
المؤلفون: Scott Wardwell, Lindsey W. Eichinger, Biplab Das, Sen Zhang, J. Graeme Hodgson, Sara Nadworny, Victor M. Rivera, Emily Y. Ye
المصدر: Cancer Research. 75:781-781
مصطلحات موضوعية: Alectinib, Cancer Research, Ceritinib, Crizotinib, medicine.drug_class, business.industry, Cancer, medicine.disease, In vitro, Tyrosine-kinase inhibitor, ALK inhibitor, Oncology, In vivo, hemic and lymphatic diseases, medicine, Cancer research, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::be00c45056b3701a755ce367752a3b76
https://doi.org/10.1158/1538-7445.am2015-781 -
5
المؤلفون: John Iuliucci, Shuangying Liu, Victor M. Rivera, Wei-Sheng Huang, Frank Wang, Qurish K. Mohemmad, Tim Clackson, Juan J. Miret, Scott Wardwell, Narayana I. Narasimhan, David C. Dalgarno, Dung Yu Chun, Jeffrey A. Keats, Feng Li, Rana Anjum, Yaoyu Ning, Lauren Moran, Yihan Wang, William C. Shakespeare, Mathew Thomas, Emily Y. Ye, Sen Zhang
المصدر: Cancer Research. 70:3623-3623
مصطلحات موضوعية: Cancer Research, Chemistry, medicine.drug_class, ALK Gene Rearrangement, Cancer, Pharmacology, medicine.disease, ALK inhibitor, Oncology, In vivo, hemic and lymphatic diseases, medicine, Anaplastic lymphoma kinase, Potency, IC50, Anaplastic large-cell lymphoma
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6510daf6d8b96f09c549f29f8dc91fc4
https://doi.org/10.1158/1538-7445.am10-3623